Hair-thin fiber can control thousands of brain neurons simultaneously
November 4, 2025
Fiber-optic technology revolutionized the telecommunications industry and may soon do the same for brain research.
Fiber-optic technology revolutionized the telecommunications industry and may soon do the same for brain research.
For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a crucial part of the human brain known as the corpus callosum—the thick band of nerve fibers that connects the brain’s left and right hemispheres. The findings open new pathways for discoveries about mental illness, neurological disorders and other diseases related to defects in this part of the brain.
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart problems, like heart attacks and heart failure, the heart muscles become damaged and are difficult to treat and repair.
The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.
Having already submitted an application with the FDA, Tulyp is now eyeing a Series A financing round to capture more clinical data and advance R&D.
Aqua Medical has received an investigational device exemption (IDE) from the FDA for its ablation device intended to treat diabetes, the company told MassDevice ahead of an official announcement later today.
Fujifilm Sonosite announced today that it launched the Sonosite MT, its latest portable ultrasound system offering.
Bioelectronic devices link microbes and materials to convert chemical signals into electrical outputs for sensing, energy, and synthesis. Unlocking this potential requires systems that can interrogate electroactive cells rapidly and at scale, but traditional bioelectrochemical platforms remain costly, bulky, and low throughput.
The increasing demand for real-time, wireless, and sustainable motion monitoring in applications such as personal health, professional sports, and human-machine interactions calls for wearable devices that are lightweight and battery free.
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — The U.S. Food and Drug Administration (“FDA”) has granted QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global leader of in vitro diagnostics, 510(k) clearance for the VITROS hs Troponin I Reagent Pack (the “VITROS hs Troponin I Assay”). The assay is intended for the quantitative measurement of cardiac troponin I (cTnI) in human plasma (heparin) to aid in the diagnosis of myocardial infarction (MI).